By Tushar Patel Vice President, US Sleep-Wake Commercial and Global Strategic Marketing, Neurology Business Group Each March, many Americans look forward to advancing our clocks by one hour as...

Ivan Cheung, Chairman, Eisai Inc. and Global President, Neurology Business Group, Eisai Co., Ltd. & Harald Hampel, MD, PhD, Vice President, Chief Medical Officer, Neurology Business Group, Eisai Inc.

By Renee Campbell, MD, MBA, MPH, Global Value and Access Epilepsy and Sleep lead, Genevieve De Sousa Meier, Executive Director, Head of Global Value and Access, and Amir Abbas Tahami Monfared,...

By Feride Frech, PhD, MPH, Senior Director, US HEOR & RWE, Eisai Inc, and Timothy Juday, Director, US HEOR & RWE, Eisai Inc. Insomnia, the most common sleep-wake disorder, is prevalent in the...

Harald Hampel, MD, PhD Vice President, Chief Medical Officer, Neurology Business Group, Eisai Inc. Alzheimer’s disease (AD) is a devastating neurodegenerative disease. It is estimated to affect...